 |
½ÅÀç±¹
|
|
Genetic factors in ethnicity (±¸µÎ¹ßÇ¥ )
|
|
| The 2nd Asian Clinical Trial Update / ÀϺ» / 2010.11. [LINK ] |
|
 |
|
|
 |
¼ÕÁöÈ«
|
|
Phase 0 studies including microdosing (±¸µÎ¹ßÇ¥ )
|
|
| The 6th Joint Symposium of KSCPT and JSCPT 2010 / 2010.11.12 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
|
How close are we to personalized pharmacotherapy based on the pharmacogenomics biomarker? (±¸µÎ¹ßÇ¥ )
|
|
| The 20th Japan-Korea Joint Seminar on Pharmacology / ÀϺ» / 2010.11.25-27 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
|
Pharmacogenomics of Antiplatelet and Anticoagulation (±¸µÎ¹ßÇ¥ )
|
|
| Personalized healthcare for Global Community(KSCPT-ASCPT Joint Symposium) / 2010.11.12 [LINK ] |
|
 |
|
|
 |
¼ÕÁöÈ«
|
|
Investigators perspective (±¸µÎ¹ßÇ¥ )
|
|
| DIA 2010 Korea Meeting / 2010.11. [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
|
The Asian Network for Pharmacogenomics Research(ANPR) to bridge the gap between academic PGx studies and clinical applications (±¸µÎ¹ßÇ¥ )
|
|
| The 55th Annual Meeting of the Japan Society of Human Genetics / 2010.10.27-30 [LINK ] |
|
 |
|
|
 |
·ù±¤Çö
|
|
Metabolomics for the Prediction of Antihypertensive's Drug Response (±¸µÎ¹ßÇ¥ )
|
|
| The 51th Annual Meeting and International Symposium of Korean Society of Life Science / 2010.10 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
|
Genotype guided personalized therapy for increasing drug safety (±¸µÎ¹ßÇ¥ )
|
|
| The 1st Global Drug Safety Conference and Exposition / 2010.10.16-18 [LINK ] |
|
 |
|
|
 |
½ÅÀç±¹
|
|
Utilization of pharmacogenomics biomarkers in personalized pharmacotherapy and in clinical trials (±¸µÎ¹ßÇ¥ )
|
|
| Turkish Pharmacological Society(TPS) Conference / 2010.09.01 [LINK ] |
|
 |
|
|
 |
ÀÌ»ó¼·
|
|
Identification of P2Y12 single-nucleotide polymorphisms and their association with ADP-induced platelet aggregation (±¸µÎ¹ßÇ¥ )
|
|
| 9th International ISSX Meeting / 201009 [LINK ] |
|
 |
|